Concepedia
Statistics
Publications
11
Citations
547
H-Index
Active since
2018
Affiliations
University of Liverpool(Current)
Vanderbilt University
Liverpool School of Tropical Medicine
Nagoya University
Mahidol University
Kangsa Amporndanai is an author at University of Liverpool specializing in drug discovery, pharmacology, and enzyme inhibition.
Publications per year
2018–2024
Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives
Kangsa Amporndanai, Xiaoli Meng, Weijuan Shang et al. · Nature Communications · 2021 · 249 citations · Full text
Life Sciences, Medicinal Chemistry, Pharmacology +17
Novel Selenium-based compounds with therapeutic potential for SOD1-linked amyotrophic lateral sclerosis
Kangsa Amporndanai, Michael S. Rogers, Seiji Watanabe et al. · EBioMedicine · 2020 · 56 citations · Full text
Medicine, Neurology, Pharmacology +17
Purification and Structural Characterization of Aggregation-Prone Human TDP-43 Involved in Neurodegenerative Diseases
Gareth S. A. Wright, Tatiana F. Watanabe, Kangsa Amporndanai et al. · iScience · 2020 · 46 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +17
Ebselen as template for stabilization of A4V mutant dimer for motor neuron disease therapy
Varunya Chantadul, Gareth S. A. Wright, Kangsa Amporndanai et al. · Communications Biology · 2020 · 44 citations · Full text
Life Sciences, Molecular Biology, Neuroscience +17
Potent Antimalarial 2-Pyrazolyl Quinolone <i>bc</i><sub>1</sub> (Q<sub>i</sub>) Inhibitors with Improved Drug-like Properties
W. David Hong, Suet C. Leung, Kangsa Amporndanai et al. · ACS Medicinal Chemistry Letters · 2018 · 34 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +15
1–5 of 11